Welcome to the Sommetrics newsroom. Here you’ll find up-to-date information about the company, including the latest news releases, as well as coverage on sleep disorders and the impact poor quality sleep and snoring can have on your health and bed partner.
Sommetrics Strengthens its Management Team
San Diego, March 25, 2015 – Sommetrics announced that it has enhanced its organizational capabilities with the appointment of three executives to its management team and the expansion of one executive’s role. “I am very pleased to have the opportunity to add several accomplished individuals to our management team,” said Dr. Richard Rose, Chief Executive Officer. “Their experience and skill will make significant contributions in bringing cNEP® technology to market.”
Sommetrics Raises an Additional $5.2 Million in Expansion of Series B Round
San Diego, February 12, 2015 – Sommetrics, formerly 5i Sciences, announced it has raised an additional $5.2 million in an expansion of its Series B financing. These funds will be used to further the development of the Company’s proprietary cNEP™ products for the treatment of sleep apnea and related conditions.
Sommetrics Announces New Name and Appoints Dr. Jon-Erik Holty to Medical Advisory Board
San Diego, November 11, 2014 – Sommetrics, formerly 5i Sciences, announces a new name to emphasize its focus on measuring and managing sleep disorders related to airway obstruction. The Company also announced the appointment of Jon-Erik Holty, M.D. as a Senior Consultant and member of the Medical Advisory Board.
5i Sciences Announces Appointment of a Senior Healthcare Consultant and Successful Financing
San Diego – July 22, 2014 – 5i Sciences announces both the appointment of Molly Coye, M.D., M.P.H. as a Senior Consultant and the completion of a Series B financing to further development of its products in anesthesia care and sleep medicine.
5i Sciences Hires General Manager for Acute Care Product Group, Announces Favorable Clinical Results
San Diego, February 21, 2014 – 5i Sciences appoints Jan Barker as General Manager of its acute care product group and announces favorable results from a completed study in adults receiving sedation for a commonly performed medical procedure.
5i Sciences Announces Appointment of New Directors and Successful Financing
San Diego, January 28, 2014 – 5i Sciences appoints three new Directors to its Board, and raises $2 MM to further development of its products in anesthesia care and sleep medicine.